Published on 12/13/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.
New Issue: Lehman prices $12.5 million Yeelds linked to AtheroGenics
New York, Dec. 13 - Lehman Brothers Holdings Inc. priced $12.5 million of 26.90% notes in the Yield-Enhanced Equity-Linked Debt Securities (Yeelds) structure linked to AtheroGenics, Inc. common stock, according to a 424B5 filing with the Securities and Exchange Commission.
At maturity, the notes pay the value of one share of AtheroGenics stock, capped at $24.15, 50% above the initial value.
| Issuer: | Lehman Brothers Holdings Inc.
|
| Issue: | Yield-Enhanced Equity-Linked Debt Securities (Yeelds) performance-linked medium-term senior notes
|
| Underlying stock: | AtheroGenics, Inc.
|
| Amount: | $12.5 million
|
| Greenshoe: | $1.875 million
|
| Maturity: | Dec. 17, 2006
|
| Coupon: | 26.90%, payable quarterly
|
| Price: | Par of $16.10
|
| Payout at maturity: | Value of 1 share of Applied Materials stock, capped at $24.15, 50% above initial value
|
| Equity cap price: | $24.15, 50% above initial value
|
| Initial price: | $16.10
|
| Pricing date: | Dec. 9
|
| Settlement date: | Dec. 16
|
| Underwriter: | Lehman Brothers
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
